Common Contracts
10 similar Underwriting Agreement contracts by ADESTO TECHNOLOGIES Corp, Global Traffic Network, Inc., 012 SMILE.COMMUNICATIONS LTD, others
4,375,000 Shares* ADESTO TECHNOLOGIES CORPORATION Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2017 • ADESTO TECHNOLOGIES Corp • Semiconductors & related devices • New York
Adesto Technologies Corporation, a Delaware corporation (the “Company”), proposes to issue and sell 4,375,000 shares (the “Firm Shares”) of the Company’s Common Stock, $0.0001 par value per share (the “Common Stock”), to you and to the several other Underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as representative (the “Representative”). The Company has also agreed to grant to you and the other Underwriters an option (the “Option”) to purchase up to an additional 625,000 shares of Common Stock, on the terms and for the purposes set forth in Section 1(b) (the “Option Shares”). The Firm Shares and the Option Shares are referred to collectively herein as the “Shares.”
19,772,727 Shares GALENA BIOPHARMA, INC. Common Stock and Warrants to Purchase up to 11,863,636 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 7th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • New York
Galena Biopharma, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of (i) 19,772,727 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) and (ii) warrants to purchase 11,863,636 shares of Common Stock on the terms and conditions set forth in the Warrant Agreement (as defined herein) (the “Firm Warrants”, and together with the Firm Shares, the “Firm Securities”). All of the Firm Securities are to be issued and sold by the Company. The respective amounts of the Firm Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional (i) 2,965
] Shares Adesto Technologies Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 13th, 2015 • ADESTO TECHNOLOGIES Corp • Semiconductors & related devices • New York
Adesto Technologies Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate of [ ] shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional [ ] shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively called the “Shares.”
6,086,956 Shares IMMUNOMEDICS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 22nd, 2013 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Immunomedics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,086,956 shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 913,044 shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively called the “Shares.”
12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 4th, 2012 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • New York
The Company has prepared and filed in conformity with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the published rules and regulations thereunder (the “Rules”) adopted by the Securities and Exchange Commission (the “Commission”) a “shelf’ registration statement on Form S-3 (No. 333-167975), which became effective as of July 21, 2010, including a base prospectus (the “Base Prospectus”) relating to common stock, preferred stock and warrants of the Company that may be sold from time to time by the Company in accordance with Rule 415 of the Securities Act, and such amendments
Aastrom Biosciences, Inc. 46,154,000 Shares of Common Stock Class A Warrants to Purchase 34,615,500 Shares of Common Stock Class B Warrants to Purchase 23,077,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 15th, 2010 • Aastrom Biosciences Inc • Biological products, (no disgnostic substances) • New York
Aastrom Biosciences, Inc., a Michigan corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to issue and sell to you (the “Underwriter”) an aggregate of (i) 46,154,000 shares (the “Firm Shares”) of common stock, no par value per share (the “Common Stock”), (ii) Class A warrants to purchase 34,615,500 shares of Common Stock (the “Firm Class A Warrants”) and (iii) Class B warrants to purchase 23,077,000 shares of Common Stock (the “Firm Class B Warrants”, and together with the Firm Class A Warrants, the “Firm Warrants” and the Firm Warrants collectively with the Firm Shares, the “Firm Securities”). In addition, the Company proposes to grant to the Underwriter an option to purchase (i) up to an additional 6,923,100 shares of Common Stock (the “Option Shares”) and/or (ii) Class A warrants to purchase up to an additional 5,192,325 shares of Common Stock (the “Option Class A Warrants”) and/or (iii) Class B warrants to purchase up to an additional 3,461,
12,500,000 Shares ARENA PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 9th, 2009 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • New York
Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you (the “Underwriter”), an aggregate of 12,500,000 shares (the “Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”).
] Shares Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2007 • 012 SMILE.COMMUNICATIONS LTD • Communications services, nec • New York
Prior to the execution of this Agreement, the Company was a wholly-owned subsidiary of Internet Gold-Golden Lines Ltd., a company organized under the laws of the State of Israel (the “Parent”).
4,500,000 Shares Global Traffic Network, Inc. Common Stock, Par Value $0.001 Per Share Underwriting AgreementUnderwriting Agreement • August 1st, 2007 • Global Traffic Network, Inc. • Services-miscellaneous business services • New York
Introductory. Global Traffic Network, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,500,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 675,000 shares (the “Optional Shares”) of Common Stock, as provided in Section 2. The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Shares.” Oppenheimer & Co. (“Oppenheimer”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Shares.
4,500,000 Shares Global Traffic Network, Inc. Common Stock, Par Value $0.001 Per Share Underwriting AgreementUnderwriting Agreement • July 20th, 2007 • Global Traffic Network, Inc. • Services-miscellaneous business services • New York
Introductory. Global Traffic Network, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,500,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 675,000 shares (the “Optional Shares”) of Common Stock, as provided in Section 2. The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Shares.” Oppenheimer & Co. (“Oppenheimer”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Shares.
